Insiders · LXEO

Narinder Pal Bhalla

Chief Medical Officer at Lexeo Therapeutics, Inc. (LXEO) since January 2026

Narinder Pal Bhalla has filed 4 insider reports with the SEC since February 2026, as chief Medical Officer at Lexeo Therapeutics, Inc. (LXEO). In the last 12 months Narinder Pal Bhalla sold $98.6K of stock on the open market. The latest filing, on September 28, 2026, reports grant or award at Lexeo Therapeutics, Inc. (LXEO).

Filings
4
Companies
1
Bought on market
None
Sold on market
$98.6K

Companies where Narinder Pal Bhalla is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Lexeo Therapeutics, Inc. logo
LXEO
Lexeo Therapeutics, Inc.
Chief Medical Officersince January 202684,908$98.6K$2.96Sep 28, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Narinder Pal Bhalla with

Other insiders at the same companies

Questions about Narinder Pal Bhalla

What is Narinder Pal Bhalla's role at Lexeo Therapeutics, Inc.?
Narinder Pal Bhalla reports to the SEC as chief Medical Officer at Lexeo Therapeutics, Inc. (LXEO), according to the latest filing on September 28, 2026.
How many shares does Narinder Pal Bhalla own?
After the latest filing that states it, Narinder Pal Bhalla directly owned 84,908 shares of Lexeo Therapeutics, Inc. (LXEO). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Narinder Pal Bhalla bought or sold stock recently?
The most recent open-market sale was on July 1, 2026: sold 22,306 shares of Lexeo Therapeutics, Inc. (LXEO) for $98.6K at an average of $4.42.
How do I get alerts when Narinder Pal Bhalla files?
Follow Narinder Pal Bhalla on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Narinder Pal Bhalla filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Narinder Pal Bhalla (SEC CIK 0002109299). Totals count each trade once, skipping amendments whose original is on file, from Feb 5, 2026 on. View on SEC EDGAR · Get this as JSON